1 Min Read
Sept 20 (Reuters) - Astellas Pharma Inc
* Rating and Investment Information, Inc. (R&I) affirmed the company’s rating at “AA”-R&I
* Rating outlook stable-R&I
Source text in Japanese:goo.gl/XZ3J8d
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.